XCNQPSYC
Market cap4mUSD
Dec 23, Last price
0.02CAD
1D
0.00%
1Q
0.00%
Name
Psyched Wellness Ltd
Chart & Performance
P/E
—
P/S
17.94
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
119.97%
Rev. gr., 5y
%
Revenues
321k
+2,149.52%
Net income
-3m
L-27.35%
CFO
-3m
L-1.83%
Profile
Psyched Wellness Ltd., a health supplements company, engages in the production and distribution of artisanal, medicinal mushrooms and associated consumer packaged goods. It offers Amanita Muscaria Tincture, which soothes the body, tackles physical distress, reduce stress, ease muscular tension, and promotes restorative sleep. The company was formerly known as Duncan Park Holdings Corporation and changed its name to Psyched Wellness Ltd. in July 2020. Psyched Wellness Ltd. was incorporated in 2019 and is based in Toronto, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑11 | 2022‑11 | 2021‑11 | 2020‑11 | 2019‑11 | 2018‑11 | 2017‑11 | 2016‑11 | 2015‑11 | |
| Income | |||||||||
Revenues | 321 2,149.52% | 14 | |||||||
Cost of revenue | 3,552 | 4,086 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (3,231) | (4,072) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | 430 | ||||||||
Tax Rate | |||||||||
NOPAT | (3,231) | (4,503) | |||||||
Net income | (3,433) -27.35% | (4,726) 5.07% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 6,789 | ||||||||
BB yield | -83.65% | ||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | 129 | ||||||||
Net debt | (6,128) | (2,568) | |||||||
| Cash flow | |||||||||
Cash from operating activities | (3,033) | (3,090) | |||||||
CAPEX | (11) | (92) | |||||||
Cash from investing activities | (45) | 127 | |||||||
Cash from financing activities | 6,642 | ||||||||
FCF | (3,643) | (4,755) | |||||||
| Balance | |||||||||
Cash | 6,128 | 2,568 | |||||||
Long term investments | |||||||||
Excess cash | 6,112 | 2,567 | |||||||
Stockholders' equity | 5,569 | 1,064 | |||||||
Invested Capital | 1,466 | 2,049 | |||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 162,318 | 134,631 | |||||||
Price | 0.05 -41.18% | 0.09 -41.38% | |||||||
Market cap | 8,116 -29.08% | 11,444 -36.68% | |||||||
EV | 1,988 | 8,876 | |||||||
EBITDA | (3,225) | (4,071) | |||||||
EV/EBITDA | |||||||||
Interest | 430 | ||||||||
Interest/NOPBT | |||||||||